These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7524703)

  • 1. B cell number and function in Graves' disease.
    Wilson R; Pearson C; McKillop JH; Thomson JA
    Autoimmunity; 1994; 17(3):251. PubMed ID: 7524703
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseases.
    Markeljević J; Batinić D; Uzarević B; Bozikov J; Cikes N; Babić-Naglić D; Horvat Z; Marusić M
    J Rheumatol; 1994 Dec; 21(12):2225-30. PubMed ID: 7535356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial analysis of the effects of methimazole therapy on circulating B cell subsets in Graves' disease.
    Corrales JJ; Orfao A; López A; Ciudad J; Mories MT
    J Endocrinol; 1996 Nov; 151(2):231-40. PubMed ID: 8958783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities in immunoregulatory CD5+ B cells precede the diagnosis of multiple myeloma.
    Paglieroni T; MacKenzie MR; Caggiano V
    Ann N Y Acad Sci; 1992 May; 651():486-7. PubMed ID: 1376067
    [No Abstract]   [Full Text] [Related]  

  • 5. CD5-positive and CD5-negative rheumatoid factor-secreting B cells in IgA nephropathy, rheumatoid arthritis and Graves' disease.
    Jones BM; Cheng IK; Wong RW; Kung AW
    Scand J Immunol; 1993 Dec; 38(6):575-80. PubMed ID: 7504827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked increase of CD5 + B cells in hyperthyroid Graves' disease.
    Iwatani Y; Amino N; Kaneda T; Ichihara K; Tamaki H; Tachi J; Matsuzuka F; Fukata S; Kuma K; Miyai K
    Clin Exp Immunol; 1989 Nov; 78(2):196-200. PubMed ID: 12412748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
    Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
    Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD5+ B-cells at the onset of type I diabetes and in the prediabetic period.
    Smerdon RA; Peakman M; Hussain MJ; Wong FS; Watkins PJ; Leslie RD; Vergani D
    Diabetes Care; 1994 Jul; 17(7):657-64. PubMed ID: 7523048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD5 expression in human B-cell populations.
    Youinou P; Jamin C; Lydyard PM
    Immunol Today; 1999 Jul; 20(7):312-6. PubMed ID: 10379049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases.
    Bossowski A; Urban M; Stasiak-Barmuta A
    J Pediatr Endocrinol Metab; 2003 Jan; 16(1):63-70. PubMed ID: 12585342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial study of CD5+ and CD5- B cell subpopulations in 335 HIV seropositive patients.
    Vuillier F; Scott-Algara D; Tortevoye P; Pialoux G; Dighiero G
    Clin Exp Immunol; 1991 Sep; 85(3):476-80. PubMed ID: 1716542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD5 B1 cells in the specificity repertoire to self/non-self antigens.
    Bell CG
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):287S. PubMed ID: 7693521
    [No Abstract]   [Full Text] [Related]  

  • 13. CD5 B cells in autoimmune and non immune-mediated thyroid dysfunctions.
    Afeltra A; Ferri GM; Amoroso A; Leri O; Pellegrino C; Guido F; Garzia P; Paggi A
    Endocr Res; 1997; 23(1-2):81-94. PubMed ID: 9187540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bar Mitzvah for B-1 cells: how will they grow up?
    Tarakhovsky A
    J Exp Med; 1997 Mar; 185(6):981-4. PubMed ID: 9091589
    [No Abstract]   [Full Text] [Related]  

  • 15. CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease.
    Neil GA; Summers RW; Cheyne BA; Capenter C; Huang WL; Kansas GS; Waldschmidt TJ
    Dig Dis Sci; 1992 Sep; 37(9):1390-5. PubMed ID: 1380423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparative isolation of murine CD5 B cells by panning and magnetic beads.
    Metzger DW; Metzger CA; Ling LA; Hurst JS; Van Cleave VH
    Ann N Y Acad Sci; 1992 May; 651():75-7. PubMed ID: 1376090
    [No Abstract]   [Full Text] [Related]  

  • 17. Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsets.
    Ekşioglu-Demiralp E; Kibaroglu A; Direskeneli H; Yavuz S; Karsli F; Yurdakul S; Yazici H; Akoglu T
    J Rheumatol; 1999 Apr; 26(4):826-32. PubMed ID: 10229403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells.
    Corrales JJ; López A; Ciudad J; Mories MT; Miralles JM; Orfao A
    J Endocrinol; 1997 Dec; 155(3):491-500. PubMed ID: 9487994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced numbers of CD8+ T cells and B cell-expression of Leu-8 antigen in peripheral blood of patients with primary biliary cirrhosis.
    Moreno-Otero R; Civeira MP; Suou T; Kanof ME; James SP; Jones EA
    Hepatogastroenterology; 1994 Jun; 41(3):239-43. PubMed ID: 7525431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic monitoring after organ transplantation: relationship between Epstein-Barr virus infection and CD19+ B cells measured by flow cytometry.
    Morrissey PE; Lorber KM; Marcarelli M; Bia MJ; Kliger AS; Lorber MI
    Transplant Proc; 1995 Feb; 27(1):1428-30. PubMed ID: 7533384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.